07:00 , Sep 2, 2013 |  BC Week In Review  |  Clinical News

Avioq HTLV-I/II Microelisa System regulatory update

Avioq said Health Canada approved in July its Avioq HTLV-I/II Microelisa System to detect antibodies to human T lymphotropic virus Type I (HTLV-I) and Type II (HTLV-II) in serum or plasma. The enzyme-linked immunosorbent assay...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Clinical News

Avioq HTLV-I/II Microelisa System regulatory update

FDA approved Avioq's Avioq HTLV-I/II Microelisa System to detect antibodies to human T lymphotropic virus Type I (HTLV-I) and Type II (HTLV-II) in blood and blood components. The enzyme-linked immunosorbent assay (ELISA) may be used...